Skip to main content
SpringerLink
Log in

Alpelisib/enoxaparin-sodium/sirolimus

Various toxicities: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Remy A, et al. Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data. Pediatric Blood and Cancer 69: e29897, No. 10, Oct 2022. Available from: URL: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1545-5017

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alpelisib/enoxaparin-sodium/sirolimus. Reactions Weekly 1937, 30 (2022). https://doi.org/10.1007/s40278-022-29710-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29710-6

Search

Navigation